Trade Report: Today: Allscripts Healthcare Solutions Inc. (MDRX) Sees Significant Decrease in Short Interest

Today: Allscripts Healthcare Solutions Inc. (MDRX) Sees Significant Decrease in Short Interest

Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) saw a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 13,718,743 shares, a drop of 16.8% from the October 31st total of 16,489,242 shares. Currently, 7.5% of the shares of the company are short sold. Based on an average daily volume of 4,054,051 shares, the short-interest ratio is presently 3.4 days.

In other news, CEO Paul Black sold 15,000 shares of the stock in a transaction that occurred on Thursday, September 15th. The stock was sold at an average price of $13.00, for a total transaction of $195,000.00. Following the transaction, the chief executive officer now owns 1,177,009 shares in the company, valued at $15,301,117. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP James Hewitt sold 17,500 shares of the stock in a transaction that occurred on Thursday, September 15th. The stock was sold at an average price of $13.00, for a total value of $227,500.00. Following the transaction, the senior vice president now owns 158,104 shares in the company, valued at approximately $2,055,352. The disclosure for this sale can be found here. Insiders own 0.75% of the company’s stock.

Large investors have recently bought and sold shares of the company. Seven Eight Capital LLC purchased a new position in Allscripts Healthcare Solutions during the first quarter valued at $102,000. Riverhead Capital Management LLC boosted its position in Allscripts Healthcare Solutions by 63.7% in the third quarter. Riverhead Capital Management LLC now owns 8,500 shares of the company’s stock valued at $112,000 after buying an additional 3,308 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Allscripts Healthcare Solutions by 23.3% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,618 shares of the company’s stock valued at $113,000 after buying an additional 1,626 shares during the last quarter. Two Sigma Securities LLC purchased a new position in Allscripts Healthcare Solutions during the third quarter valued at $134,000. Finally, Harbour Capital Advisors LLC purchased a new position in Allscripts Healthcare Solutions during the second quarter valued at $136,000.

MDRX has been the topic of a number of recent research reports. Leerink Swann upgraded Allscripts Healthcare Solutions from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $16.00 to $17.00 in a research note on Tuesday, August 23rd. Zacks Investment Research lowered Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research note on Tuesday, October 25th. Cowen and Company lowered Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and lowered their price objective for the stock from $17.00 to $14.00 in a research note on Thursday, September 8th. Argus restated a “buy” rating and set a $19.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Sunday, October 23rd. Finally, Canaccord Genuity set a $17.00 price objective on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a research note on Saturday, November 19th. Eleven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $15.47.

Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at 11.19 on Monday. The firm’s 50-day moving average price is $11.73 and its 200 day moving average price is $12.85. The firm’s market capitalization is $2.07 billion. Allscripts Healthcare Solutions has a one year low of $9.80 and a one year high of $15.78.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its earnings results on Thursday, November 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by $0.01. The company had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $414.92 million. Allscripts Healthcare Solutions had a positive return on equity of 5.79% and a negative net margin of 0.14%. The company’s revenue was up 10.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.13 EPS. On average, equities analysts anticipate that Allscripts Healthcare Solutions will post $0.56 earnings per share for the current fiscal year.

Allscripts Healthcare Solutions Company Profile

Related posts

Leave a Comment